Table 4.

Acute Myeloid Leukemia (AML) Cytogenetic Risk Groups

Karyotype	Frequency, %	Complete remission, %	Event-free survival, %
Favorable
t(8;21)	5-10	90	60-70
inv(16)	5-10	90	60-70
t(15;17)	5-10	80-90	70
Intermediate
Diploid, –Y	40-50	70-80	30-40
Unfavorable
−5/–7	20-30	50	5-10
+8	10	60	10-20
11q23, 20q-, other	10-20	60	10